Fumihiko Urano, MD, PhD

Fumihiko Urano, MD, PhD

Specializes In
  • Endocrinology
Languages Spoken
  • English
  • Japanese


Sees Patients For

Medical genetics, Wolfram syndrome, Wolfram-like syndrome, WFS1-related disorders, genetic testing and counseling, atypical diabetes, genetic forms of diabetes, endocrine genetic diseases.

Hospital Affiliations

  • Barnes-Jewish Hospital



Board Certifications

  • Medical Genetics and Genomics

Academic Title(s)

Samuel E. Schechter Professor of Medicine, Professor of Medicine and Pathology & Immunology, Division of Endocrinology, Metabolism and Lipid Research

Research Interests

Wolfram syndrome, gene therapy, regenerative therapy, biomarkers.

Publications & Research

View research profile »


Clinical Fellowship: Medical Genetics and Genomics

2020 Washington University in St. Louis School of Medicine, St. Louis, MO

Research Fellowship: Molecular Pathology

2002 New York University School of Medicine, New York, New York

Residency: Pathology, Medical Genetics and Oncology

1998 Keio University School of Medicine, Tokyo, Japan

Medical Degree

1994 Keio University School of Medicine, Tokyo, Japan

Financial Disclosures
  • Cure4WOLFRAM
    • Equity: Yes
    • Reporting Date: 05/01/2024
  • Opris Biotechnologies
    • Consulting/Advisory Board: $20,000 - $39,999
    • Reporting Date: 05/01/2024

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.